Results 211 to 220 of about 233,409 (358)

TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations. [PDF]

open access: yesBrain
Kosmanopoulos GP   +20 more
europepmc   +1 more source

Optically pumped magnetometers detect altered maximal muscle activity in neuromuscular disease. [PDF]

open access: yesFront Neurosci, 2022
Semeia L   +13 more
europepmc   +1 more source

The Influence of Schwann Cell Metabolism and Dysfunction on Axon Maintenance

open access: yesGlia, EarlyView.
Sensory neurons depend on Schwann cells for survival. Schwann cells provide energy for axons during rapid firing or after injury. Dysregulated metabolism in Schwann cells can lead to the production of neurotoxic lipids and axon degeneration. ABSTRACT Schwann cells are the glial cells in the peripheral nervous system responsible for the production of ...
Rose Follis   +2 more
wiley   +1 more source

Protocol to monitor live-cell, real-time, mitochondrial respiration in mouse muscle cells using the Resipher platform

open access: yesSTAR Protocols
Summary: Mitochondrial function is typically assessed by measuring oxygen consumption at a given time point. However, this approach cannot monitor respiratory changes that occur over time.
Matthew Triolo, Mireille Khacho
doaj  

Use of assistive technology to assess distal motor function in subjects with neuromuscular disease. [PDF]

open access: yesPLOS Digit Health
Vincent-Genod D   +13 more
europepmc   +1 more source

Visual versus quantitative analysis of muscle ultrasound in neuromuscular disease. [PDF]

open access: yesMuscle Nerve, 2022
Wijntjes J   +4 more
europepmc   +1 more source

EFFECTS OF CREATINE ON MUSCULAR STRENGTH AND BODY COMPOSITION AMONG PATIENTS WITH NEUROMUSCULAR DISEASE

open access: bronze, 2001
Kerry S. Kuehl   +3 more
openalex   +1 more source

Macrophage Targeting Protects Nerve Structure and Improves Muscle Innervation in a Mouse Model of Charcot‐Marie‐Tooth 2J

open access: yesGlia, EarlyView.
Hemizygous P0T124M mice develop a late‐onset axonopathy at 18 months of age. Pharmacological macrophage targeting with PLX5622 prevents distal axon degeneration in P0T124M mutant mice and mitigates motor impairment. ABSTRACT In several previous studies, we have shown that macrophage targeting with the CSF‐1 receptor specific kinase (c‐FMS) inhibitor ...
Dennis Klein   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy